All In MedTech

Device Trial Radar · NCT01387360

Presbyopic Supracor Treatment for Near Myopic/Hyperopic Pseudophakic Eyes

A Prospective Study to Evaluate the Safety and Effectiveness of the Supracor Presbyopic Treatment Algorithm for Pseudophakic Eyes Using Lasik

Last checked: Nov 20, 2026Latest source record: May 20, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

33

Actual

Start

Jun 2011

Primary completion

Oct 2013

Study completion Oct 2014

Sponsor

Lead sponsor
Technolas Perfect Vision GmbHNot on our public-company list
Sponsor type
Industry
First posted
Jul 4, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 45 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical study has been planned to determine the effectiveness of a special laser treatment intended to correct both near and distance vision in patients who have undergone previous cataract surgery.

Conditions

  • Myopia
  • Hyperopia
  • Presbyopia

Interventions

  • SupracorDevice

    The presbyopic treatment consists of a standard treatment for distance vision and the procedure known as SUPRACOR addition to correct near vision. The SUPRACOR addition provides a multifocal ablation with a central near addition with an aberration controlled transition zone towards the periphery, thereby allowing good focus over a range of object distances.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percentage of treated eyes with a best corrected high contrast distance VA of 20/25 or betterTime frame: 6M

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asian Eye Institute

    Makati, Manila, Philippines

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.